# Forbes Daily: The Cannabis Industry’s High Hopes For Federal Reform > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-federal-reform-impact-clinical-practice/ > **Published:** 2026-04-17T19:06:34-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:05:20-04:00 > **Clinical Summary:** Explore how cannabis federal reform impacts clinical practice, patient access, and regulation in the evolving cannabis industry landscape. --- ✦ New CED Clinical Relevance  #82High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic PolicyFederal RegulationClinical PracticePatient AccessHealthcare Systems Why This Matters Federal cannabis reform directly impacts clinical practice by potentially standardizing product quality, enabling interstate patient access, and allowing physicians to prescribe rather than recommend cannabis therapeutics. Banking and research restrictions currently limit both treatment options and clinical evidence generation. Clinical Summary The [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) anticipates federal policy changes that could reclassify cannabis scheduling, enable banking services, and expand research opportunities. Current federal prohibition creates clinical barriers including inconsistent product standards, limited research funding, and restricted physician prescribing authority. Any federal reform would likely maintain state-level regulatory frameworks while removing interstate commerce barriers. Dr. Caplan’s Take “Federal reform is clinically inevitable, but the timeline remains unpredictable. I advise patients and clinicians to focus on optimizing care within current state frameworks rather than delaying treatment decisions for potential future changes.” Clinical Perspective 🧠 Clinicians should stay informed about evolving federal policy but continue evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) within existing state regulations. [Patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions should be based on current therapeutic needs and available products, not speculation about future regulatory changes. Monitor professional medical organizations for guidance on practice modifications as federal policy evolves. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Forbes%20Daily%3A%20The%20Cannabis%20Industry%27s%20High%20Hopes%20For%20Federal%20Reform%20%40drcaplan&url=https%3A//www.forbes.com/sites/daniellechemtob/2026/04/17/forbes-daily-the-cannabis-industrys-high-hopes-for-federal-reform/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.forbes.com/sites/daniellechemtob/2026/04/17/forbes-daily-the-cannabis-industrys-high-hopes-for-federal-reform/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Forbes%20Daily%3A%20The%20Cannabis%20Industry%27s%20High%20Hopes%20For%20Federal%20Reform%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.forbes.com/sites/daniellechemtob/2026/04/17/forbes-daily-the-cannabis-industrys-high-hopes-for-federal-reform/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.forbes.com/sites/daniellechemtob/2026/04/17/forbes-daily-the-cannabis-industrys-high-hopes-for-federal-reform/](https://www.forbes.com/sites/daniellechemtob/2026/04/17/forbes-daily-the-cannabis-industrys-high-hopes-for-federal-reform/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Congress Has The Votes To Pass Federal Marijuana Reform, Top House Democrat Says](https://cedclinic.com/federal-marijuana-reform-congressional-support/) Learn about the latest congressional developments supporting federal marijuana reform and what it means for the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/). [Read More](https://cedclinic.com/federal-marijuana-reform-congressional-support/) [Federal Cannabis Reform Has “The Votes,” Top Dem Says (Newsletter: April 22, 2026)](https://cedclinic.com/2026-cannabis-federal-reform-votes-clinical-impact/) Stay updated with the latest newsletter detailing the political momentum behind federal cannabis reform efforts. [View Newsletter](https://cedclinic.com/2026-cannabis-federal-reform-votes-clinical-impact/) [Drug Development, Tax Breaks, Future Reimbursement Expected After Medical Marijuana …](https://cedclinic.com/cannabis-drug-development-tax-incentives-clinical-impact/) Explore how federal reform could influence [drug development](https://cedclinic.com/hydrogen-sulfide-releasing-nsaid-derivative/), tax incentives, and reimbursement in [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/). [Discover More](https://cedclinic.com/cannabis-drug-development-tax-incentives-clinical-impact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).